| ACP | Acid-activatable curcumin polymer |
| AgNPs | Silver nanoparticles |
| ALP | Alkaline Phosphatase |
| ALT | Alanine Aminotransferase |
| AST | Aspartate Aminotransferase |
| AuNP | Gold nanoparticle |
| AuNP-PAH-CUR | AuNP with poly(allylamine hydrochloride) |
| BDMC | Bisdemethoxycurcumin |
| CFA | Complete Freund’s Adjuvant |
| CIA | Collagen-induced arthritis |
| CMCAB | Carboxymethycellulose acetate butyrate |
| COX-2 | Cyclooxygenase-2 |
| CUR | Curcumin |
| DAS-28 | Disease Activity Score of 28 joints |
| DiMC | Dimethyl curcumin |
| FoxP3 | Forkhead Box P3 |
| GA/CUR | Glycyrrhizic acid nanocomplex with curcumin |
| HA | Hyaluronic acid |
| H&E | Hematoxylin and Eosin |
| HDL | High-Density Lipoprotein |
| IL-10 | Interleukin 10 |
| IL-1 β | Interleukin 1 beta |
| IL-6 | Interleukin 6 |
| ISO | International Organization for Standardization |
| LDL | Low-Density Lipoprotein |
| Lipo-DiMC | Liposome encapsulating dimethyl curcumin |
| MIA | Monoidoacetic acid or mono-iodoacetate |
| Micro-CT | Micro-computed tomography |
| MMD | Medial meniscus destabilization |
| MSU | Monosodium urate |
| Nano–CUR | Curcumin nanocarrier |
| NF-κB | Nuclear factor kappa B |
| NLCs | Nanostructured lipid carriers |
| NSAIDs | Nonsteroidal anti-inflammatory drugs |
| OARSI | Osteoarthritis Research Society International |
| OA | Osteoarthritis |
| PAH | Polyallylamine hydrochloride |
| PBS | Phosphate-buffered saline |
| PCC | Population, Concept, and Context |
| PDI | Polydispersity index |
| PLGA | Poly lactic-co-glycolic acid |
| RA | Rheumatoid arthritis |
| RCT | Randomized controlled trial |
| RoB 2 | Risk of Bias 2 |
| ROS | Reactive oxygen species |
| SJC | Swollen Joint Count |
| SLNs | Solid lipid nanoparticles |
| TGF-β | Transforming Growth Factor Beta |
| TJT | Tender Joint Count |
| TNF-α | Tumor Necrosis Factor Alpha |
| TPGS | D-α-tocopherol polyethylene glycol 1000 succinate |
| WHO | World Health Organization |